Gold, 2,3,4,6-tetraacetate
34031-32-8CC(=O)OCC1OC([S-])C(OC(C)=O)C(OC(C)=O)C1OC(C)=O.CC[PH+](CC)CC.[Au+]AUJRCFUBUPVWSZ-UHFFFAOYSA-NAuranofin can cause developmental toxicity according to state or federal government labeling requirements.
34031-32-8化学的特性White to Off-White Solid
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
用途自己抗体産生及び炎症性細胞 機能抑制作用を示します。
用途自己抗体産生及び炎症性細胞 機能抑制作用を示します。
説明Auranofin is the first orally effective gold compound to be marketed for the treatment of severe rheumatoid arthritis. It is better tolerated and more convenient than gold sodium thiomalate, which is administered intramuscularly.
使用Auranofin is a new oral gold-based antiarthritis drug. Auranofin inhibits various leukocyte activation pathways at multiple sites. Auranofin inhibits the release of inflammatory mediators from human m acrophages, basophils, and pulmonary mast cells. Auranofin is an efficient inducer of mitochondrial membrane permeability transition pore in the presence of calcium ions related to its inhibition of m itochondrial thioredoxin reductase.
定義ChEBI: An S-glycosyl compound consisting of 2,3,4,6-tetra-O-acetyl-1-thio-beta-D-glucopyranose with the sufur atom coordinated to (triethylphosphoranylidene)gold. It is administered orally fo the treatment of active progressive rheumatoid arthritis.
現在のフィルター条件では反応記録がありません。
読み込み中…